Sigma-Aldrich Announces Appointment of Michael Kanan as Vice President and Corporate ...(ch is a leading Life Science and High ...),Health
Navigation Links
Sigma-Aldrich Announces Appointment of Michael Kanan as Vice President and Corporate Controller
Date:4/10/2009
ch is a leading Life Science and High Technology company. Its chemical and biochemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.
'/>"/>
| SOURCE Sigma-Aldrich Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Sigma-Aldrich Enters Distribution Agreement With AlphaGenix, Inc.
2. Sigma-Aldrich and Atlas Antibodies Announce the Release of 2,000 New, Highly-Validated Prestige Antibodies
3. Sigma-Aldrich Shareholders Elect Directors and Ratify Auditor; Directors Declare Quarterly Dividend
4. Sigma-Aldrich Amends Credit Facility and Expands Commercial Paper Program
5. Sigma-Aldrich Licenses From NeuroSurvival Technologies a Leading Marker for Molecular Imaging of Apoptosis in Vivo
6. Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification
7. Spectrum Surgical Instruments Announces: Quality Management System Certification
8. Sutter Health Announces 2008 Financial Performance
9. Allscripts Announces Final Tax Treatment of Special Cash Dividend From the Transactions With Misys plc Completed in October 2008
10. Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
11. Burrill & Company Announces Promotions
Post Your Comments:
(Date:12/15/2009)... CHICAGO, Dec. 15 Research shows a ... return on investment as building a culture of ... improved performance(1). According to a new white paper ... wellness solutions, the workplace represents an ideal setting ... and building and sustaining a corporate culture of ...
(Date:12/15/2009)... CHICAGO, Dec. 15 The following is being ... ,, Remarks by: Vera Rulon, MS, RHIT, CCS, ... morning, everyone and thank you joining us... ,, On ... great pleasure to introduce our next chief executive officer, ... embarked on a nationwide search for someone who we ...
(Date:12/15/2009)... midwife are generally associated with different tests and/or ... more. Women, doctors and midwives are agreed that ... sexual health, reveals a thesis from the Sahlgrenska ... Many young women see sex as a problem, ... answered questions about their sex lives, their relationships ...
(Date:12/15/2009)... Spanish scientists have found the first potential immunological clue ... by the pandemic H1N1 virus. , The study ... patients, 15 outpatients and 15 control subjects in 10 ... and August 2009. Researchers from the Hospital Clinico Universitario ... found high levels of a molecule called interleukin 17 ...
(Date:12/15/2009)... people really benefit from their looks, and in what ... Georgia and the University of Kansas found that yes; ... and therefore an increased sense of psychological well-being. This ... spend billions of dollars each year trying to become ... issue of Personal Relationships , also determines that ...
Breaking Medicine News(10 mins):Health News:Optimizing Corporate Culture is Critical to the Success of Wellness Programs 2Health News:Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST 2Health News:More about sex and relationships needed at gynecological visits 2Health News:First immunological clue to why some H1N1 patients get very ill or die 2Health News:The importance of attractiveness depends on where you live 2[0] Optimizing Corporate Culture is Critical to the Success of Wellness Programs[0] Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST[0] More about sex and relationships needed at gynecological visits[0] First immunological clue to why some H1N1 patients get very ill or die[0] The importance of attractiveness depends on where you live
... Inc. (NYSE: ARE ) today announced the Company ... Monday, February 9, 2009, at 3:00 p.m. Eastern Time (ET), ... results for the fourth quarter and year ended December 31, ... before the market opens on Monday, February 9, 2009. , ...
... 2 Walden University,s M.S. in ... Council for Accreditation,of Counseling and Related Educational Programs ... for Higher Education,Accreditation that accredits counselor preparation master,s ... education institution that offers a,CACREP-accredited M.S. degree in ...
... the formation of fibroblasts during development also promotes their ... et al. in the February 9, 2009 issue of ... conversion of epithelial cells into fibroblast-like mesenchymal cells is ... The transcription factor Snail1 induces this conversion (known as ...
... Pharmacy Retail Level, Kidz-Med Thermofocus 5-in-1 Debuts on "Fox ... Resources (Pink Sheets: ASFX) today announced that pharmacy retail ... of 2008 compared to the 4th quarter of 2007. ... the economic recession, since implementing particular offline and online ...
... Availity, LLC, a leading health,information network, today ... of medical and behavioral health management software, ... transactions. Health care,providers with MedEZ software can ... Information Network. The partnership provides MedEZ,customers with ...
... @Heart Campaign Encourages the 44 Million Women Living with or ... Heart Health -WASHINGTON, Feb. 2 Heart disease is the ... still not receiving the same in-hospital treatment that men do ... more likely to die.(ii) In an effort to address ...
Other Medicine News:Health News:Walden University's M.S. in Mental Health Counseling Program Receives CACREP Accreditation 2Health News:Walden University's M.S. in Mental Health Counseling Program Receives CACREP Accreditation 3Health News:Fibroblasts invade at a snail's pace 2Health News:Q4 2008 Sales Increase for Health and Safety Products Company 2Health News:Q4 2008 Sales Increase for Health and Safety Products Company 3Health News:Availity Partners With MedEZ 2Health News:Bayer Healthcare and WomenHeart Launch Strong @Heart Campaign 2Health News:Bayer Healthcare and WomenHeart Launch Strong @Heart Campaign 3Health News:Bayer Healthcare and WomenHeart Launch Strong @Heart Campaign 4Health News:Bayer Healthcare and WomenHeart Launch Strong @Heart Campaign 5Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2008 Operating and Financial Results Conference Call and Web Cast on February 9, 2009Walden University's M.S. in Mental Health Counseling Program Receives CACREP AccreditationFibroblasts invade at a snail's paceQ4 2008 Sales Increase for Health and Safety Products CompanyAvaility Partners With MedEZBayer Healthcare and WomenHeart Launch Strong @Heart Campaign
(Date:12/15/2009)... Bend Research Inc. announced,today that its clients ... an,excipient used in technologies developed by the firm to ... Bend Research clients may now reference ... regulatory filings with the FDA, Bend Research officials said. ... new development and know it will assist our,clients in ...
(Date:12/14/2009)... Dec. 14 BioTrends Research Group, Inc. ... a syndicated publication offering comprehensive insight into the ... based on a comparison of self-reported treatment approaches ... level data for over 1,000 RA patients who ... To be eligible for the audit, patients had ...
(Date:12/14/2009)... 14 Seven leading cancer ... US Oncology Research participated in ... the 2009 San Antonio Breast ... at the Henry B. Gonzalez ... Texas . Fifteen others presented ...
Breaking Medicine Technology:Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 2New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 3US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9Acupuncture may bring relief for a common condition in women 54970 1Acupuncture may bring relief for a common condition in women 54970 2Switching on the power of stem cells 9639 1Switching on the power of stem cells 9639 2Princeton team learns why some drugs pack such a punch 9635 1Princeton team learns why some drugs pack such a punch 9635 2Princeton team learns why some drugs pack such a punch 9635 3[0] Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient[0] New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis[0] US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium
... Strativa,Pharmaceuticals, the proprietary products division of ... today announced that its development partner,Alfacell Corporation ... preliminary,statistical analysis of data from its confirmatory ... ONCONASE (ranpirnase), did not meet statistical,significance for ...
... Showed Clinically Meaningful Benefits for Patients with,Chemotherapy-Induced ... May 29 ,GlaxoSmithKline (GSK) today announced the ... U.S. Food and Drug Administration and new ... (casopitant), a novel,investigational NK-1 receptor antagonist. The ...
Other Medicine Technology:Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial 2Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial 3Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial 4GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 2GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 3GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 4GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 5GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 6GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 7GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant) 8Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... either EDTA K2 or EDTA K3 ... and therefore blocks the coagulation cascade. ... EDTA anticoagulated blood sample are stable ... tubes are for the examination of ...
Glass Whole Blood Tube with K3EDTA...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |